Namandje Bumpus - 15 Mar 2025 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
15 Mar 2025
Net transactions value
$0
Form type
3
Filing time
19 Mar 2025, 16:26:11 UTC
Next filing
19 Mar 2025

No securities are beneficially owned.